Literature DB >> 629993

The genetic system of the L-type pyruvate kinase forms in man. Subunit structure, interrelation and kinetic characteristics of the pyruvate kinase enzymes from erythrocytes and liver.

A Kahn, J Marie, H Garreau, E D Sprengers.   

Abstract

Pyruvate kinase (ATP: pyruvate 2-O-phosphotransferase, EC 2.7.1.40) from human liver and red cells has been purified to homogeneity; its subunit structure and some of its kinetic characteristics have been studied. The influence of a partial proteolysis by trypsin on the subunit structure, the isozymic pattern and the kinetic characteristics of red cell and liver enzyme have been investigated. From the results of this study we may conclude that: 1. Liver (L-type) pyruvate kinase is composed of 4 identical L subunits while the major form of erythrocyte enzyme (PK-R2) is a heterotetramer designated as L2L2', the molecular weight of L' being slightly higher than that of L subunits (63 000 and 58 000 respectively). Pyruvate kinase PK-R1, predominant in the erythroblasts and the young red cells, is composed of four identical L' subunits. 2. A mild tryptic attack is able to transform PK-R1 into PK-R2, then PK-R2 into pyruvate kinase L (PK-L). The same proteolytic treatment transforms the L' subunits into L ones. 3. Consequently L-type pyruvate kinase seems to be initially synthesized in the erythroid precursors as an L4' enzyme secondarily partially proteolysed into L2L2'. In liver a very active proteolytic system would be responsible for the total transformation into L4 pyruvate kinase. 4. L4' enzyme exhibits Michaelis-Menten kinetic behaviour with an apparent Michaelis constant of 3.8 mM whereas L4 enzyme shows both positive and negative homotropic interactions towards phosphoenolpyruvate and has [S] 0.5 of 1.2 mM. The characteristics of L2L2' are roughly intermediate between those of L4' and of L4. Fructose 1,6-biphosphate decreases [S]0.5 for these three pyruvate kinase forms without suppressing the differences in the apparent affinity for phosphoenolpyruvate of these enzymes. 5. L4 pyruvate kinase is more inhibited by Mg-ATP than L4', with L2L2' in the intermediate range. 6. Tryptic treatment of each enzyme form studied transforms its kinetic behaviour into that observed for L4.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 629993     DOI: 10.1016/0005-2744(78)90009-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

Review 1.  Advances in hereditary red cell enzyme anomalies.

Authors:  A Kahn; J C Kaplan; J C Dreyfus
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  Cloning and characterization of a cDNA for the cytosolic isozyme of plant pyruvate kinase: the relationship between the plant and non-plant enzyme.

Authors:  S D Blakeley; W C Plaxton; D T Dennis
Journal:  Plant Mol Biol       Date:  1990-10       Impact factor: 4.076

3.  Membrane-associated pyruvate kinase in developing guinea-pig liver.

Authors:  S M Farrow; C T Jones
Journal:  Biochem J       Date:  1986-04-01       Impact factor: 3.857

4.  Electrophoretic demonstration of heterozygosis in hereditary pyruvate kinase deficiency. An unusual method.

Authors:  A Kahn; J Marie; J L Vives-Corrons
Journal:  Hum Genet       Date:  1979-04-05       Impact factor: 4.132

5.  Postnatal changes in canine erythrocyte pyruvate kinase isozymes.

Authors:  P A Mueggler; S Carpenter; J A Black
Journal:  Biochem Genet       Date:  1983-08       Impact factor: 1.890

6.  Erythrocyte pyruvate kinase deficiency: characterization of a new variant (PK "Aarau").

Authors:  M Lakomek; H Winkler; M Scharnetzky; W Tillmann; G Laier; H R Marti; W Schröter
Journal:  Blut       Date:  1984-03

7.  Pyruvate kinase and the "high ATP syndrome".

Authors:  G E Staal; G Jansen; D Roos
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

8.  Pyruvate kinase "Göttingen 1,2": congenital hemolytic anemia, evidence of double heterozygosity, and lack of enzyme cooperativity.

Authors:  W Schröter; M Lakomek; M Scharnetzky; W Tillmann; H Winkler
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

9.  Phosphorylation of human red cell and liver pyruvate kinase. Differences between liver and erythrocyte L-type subunits.

Authors:  P Boivin; C Galand; M Estrada
Journal:  Experientia       Date:  1980-08-15

10.  Changes in glycolytic enzyme activities in aging erythrocytes fractionated by counter-current distribution in aqueous polymer two-phase systems.

Authors:  P Jimeno; A I Garcia-Perez; J Luque; M Pinilla
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.